The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
183 - 258 jobs Number of planned job losses
Announcement Date
6 June 2012
Employment effect (start)
31 July 2012
Foreseen end date
31 December 2012
Description
Pharmaceutical company Teva has announced plans to cut 258 jobs in France. Teva explained it will try to find a buyer to take over the production unit with 90 employees, to mitigate the social impact of the decision.
Teva will also try to provide up to 75 new positions within the company, which could eventually decrease the total number of the employees reduced.
The dismissals are to be completed by the end of 2012.
Sources
7 June 2012: Boursier.com
Citation
Eurofound (2012), Teva, Internal restructuring in France, factsheet number 73729, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73729.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
